• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Chukyo Iyakuhin CO., Ltd.

  • ID: 638857
  • February 2015
  • 54 Pages
  • Wright Investors Service

A textual analysis of the financial results for Chukyo Iyakuhin CO., Ltd. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description of the company, including contact information, senior officers and Wright Quality Rating analyses is also provided.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio tables (Accounting, Asset Utilization, Employee Efficiency, Fixed Charges Coverage, Leverage Analysis, Liquidity Analysis, Per-share Data and Profitability Analysis) and proprietary Wright Quality Rating analyses tables. The Wright Quality Rating, a measure of corporate risk, examines the liquidity of the stock, financial strength, profitability and corporate growth characteristics of Chukyo Iyakuhin CO., Ltd. There is a textual review of the financial results of Chukyo Iyakuhin CO., Ltd. versus Dream Vision Co Ltd, Sanwa Co Ltd and Tea Life Co Ltd. The comparative analysis of these companies compares Sales (sales, sales growth and sales READ MORE >

Note: Product cover images may vary from those shown

Company Fundamentals
- Company Profile
- Comparative Business Analysis
- Summary Analysis per Share
- Sales Analysis
- Price Analysis
- Earnings and Dividends Analysis

Financial Statement Analyses
- Balance Sheet - Common Size
- Balance Sheet - Year-Year Percent Change
- Balance Sheet - Five-Year Averages
- Income Statement - Common Size
- Income Statement - Year-Year Percent Change
- Income Statement - Five-Year Averages
- Sources of Capital

Financial Ratio Analyses
- Accounting Ratios
- Asset Utilization
- Employee Efficiency
- Fixed Charges Coverage
- Leverage Analysis
- Liquidity Analysis
- Per-Share Data
- Profitability Analysis

Wright Quality Rating Analyses
- Investment Acceptance
- Financial Strength
- Profitability and Stability
- Corporate Growth

Note: Product cover images may vary from those shown

PT Millennium Pharmacon International Terbuka, C & O Pharmaceutical Technology ( Holdings) Ltd and Apex Healthcare Bhd

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

  • Sapporo Clinical Laboratory Inc. - Product Thumbnail Image

    Sapporo Clinical Laboratory Inc.

    • Language: English
    • 54 Pages
    • Published: February 2015
    FROM
  • Minerva Holdings Company Limited - Product Thumbnail Image

    Minerva Holdings Company Limited

    • Language: English
    • 54 Pages
    • Published: August 2014
  • Dream Vision Co Ltd - Product Thumbnail Image

    Dream Vision Co Ltd

    • Language: English
    • 53 Pages
    • Published: February 2015
    FROM
  • CHUKYO IYAKUHIN Acquisition Manual - Product Thumbnail Image CHUKYO IYAKUHIN Acquisition Manual

    CHUKYO IYAKUHIN Acquisition Manual

    • Language: English
    • Published: April 2015
  • Sanwa Co Ltd - Product Thumbnail Image Sanwa Co Ltd

    Sanwa Co Ltd

    • Language: English
    • 53 Pages
    • Published: March 2015
    FROM
  • TV Direct PCL - Product Thumbnail Image

    TV Direct PCL

    • Language: English
    • 51 Pages
    • Published: March 2015
    FROM
  • Tea Life Co Ltd - Product Thumbnail Image

    Tea Life Co Ltd

    • Language: English
    • 53 Pages
    • Published: March 2015
    FROM
  • Chukyo Bank Limited (The) - Product Thumbnail Image

    Chukyo Bank Limited (The)

    • Language: English
    • 37 Pages
    • Published: March 2015
    FROM
  • Apex Healthcare Bhd - Product Thumbnail Image

    Apex Healthcare Bhd

    • Language: English
    • 54 Pages
    • Published: March 2015
    FROM
  • Zhejiang Zhenyuan Co., Ltd. - Product Thumbnail Image

    Zhejiang Zhenyuan Co., Ltd.

    • Language: English
    • 56 Pages
    • Published: March 2015
    FROM

Our Clients

Fluidigm Corporation Apple, Inc. CEVA Santé Animale Abbott Laboratories Ltd. Merck Group Allergan Inc. Pfizer, Inc.